FDA grants accelerated approval to nivolumab and ipilimumab combination for hepatocellular carcinoma

Hematology / Oncology Approvals

Source: FDA Center for Drug Evaluation and Research - What's New - March 11, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news